Edward Williams's Insider Trades & SAST Disclosures
Edward Williams's most recent trade in BioAtla Inc was a trade of 16,500 Common Stock done . Disclosure was reported to the exchange on June 13, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Edward Williams.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| BioAtla Inc | Edward Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2024 | 16,500 | 36,700 | - | 0 | Common Stock | |
| Escalade, Inc. | Edward E. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2024 | 4,300 | 4,300 | - | - | Restricted Stock Units | |
| Escalade, Inc. | Edward E. Williams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 May 2024 | 2,650 | 153,302 (1%) | 0% | - | Common Stock | |
| Escalade, Inc. | Edward E. Williams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 May 2024 | 2,650 | 2,650 | - | - | Restricted Stock Units | |
| Escalade, Inc. | Edward E. Williams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2024 | 2,500 | 150,652 (1%) | 0% | - | Common Stock | |
| Escalade, Inc. | Edward E. Williams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2024 | 2,500 | 0 | - | - | Restricted Stock Units | |
| BioAtla Inc | Edward Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2023 | 4,827 | 20,200 | - | 0 | Common Stock | |
| BioAtla Inc | Edward Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 3,958 | 8,388 | - | 0 | Common Stock | |
| BioAtla Inc | Edward Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 50,000 | 50,000 | - | - | Stock Option (Right to Buy) | |
| Escalade, Inc. | Edward E. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2023 | 5,300 | 5,300 | - | - | Restricted Stock Units | |
| BioAtla Inc | Edward Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 4,430 | 4,430 | - | 0 | Common Stock | |
| Escalade, Inc. | Edward E. Williams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2023 | 2,500 | 146,485 (1%) | 0% | - | Common Stock | |
| Escalade, Inc. | Edward E. Williams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2023 | 2,500 | 2,500 | - | - | Restricted Stock Units | |
| Escalade, Inc. | Edward E. Williams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2023 | 1,667 | 148,152 (1%) | 0% | - | Common Stock | |
| Escalade, Inc. | Edward E. Williams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2023 | 1,667 | 0 | - | - | Restricted Stock Units | |
| Escalade, Inc. | Edward E. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2022 | 5,000 | 5,000 | - | - | Restricted Stock Units | |
| Escalade, Inc. | Edward E. Williams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2022 | 2,500 | 0 | - | - | Restricted Stock Units | |
| Escalade, Inc. | Edward E. Williams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2022 | 2,500 | 142,319 (1%) | 0% | - | Common Stock | |
| Escalade, Inc. | Edward E. Williams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2022 | 1,666 | 143,985 (1%) | 0% | - | Common Stock | |
| Escalade, Inc. | Edward E. Williams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Mar 2022 | 1,666 | 1,667 | - | - | Restricted Stock Units | |
| Catalyst Biosciences Inc | Edward Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jan 2022 | 12,308 | 34,804 (0%) | 0% | 0 | Common Stock | |
| BioAtla Inc | Edward Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2021 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| Catalyst Biosciences Inc | Edward Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2021 | 2,980 | 22,496 (0%) | 0% | 0 | Common Stock | |
| Telos Corp | Edward L. Williams | EVP, COO | Sale of securities on an exchange or to another person at price $ 28.43 per share. | 29 Sep 2021 | 54,435 | 352,854 | - | 28.4 | 1,547,587 | Common Stock |
| Telos Corp | Edward L. Williams | EVP, COO | Sale of securities on an exchange or to another person at price $ 28.45 per share. | 29 Sep 2021 | 29,711 | 407,289 | - | 28.5 | 845,278 | Common Stock |
| Telos Corp | Edward L. Williams | EVP, COO | Sale of securities on an exchange or to another person at price $ 29.12 per share. | 29 Sep 2021 | 4,002 | 348,852 | - | 29.1 | 116,538 | Common Stock |
| Telos Corp | Edward L. Williams | EVP, COO | Sale of securities on an exchange or to another person at price $ 31.75 per share. | 20 Sep 2021 | 44,548 | 105,245 | - | 31.8 | 1,414,399 | Common Stock |
| Telos Corp | Edward L. Williams | EVP, COO | Sale of securities on an exchange or to another person at price $ 32.33 per share. | 20 Sep 2021 | 2,304 | 102,941 | - | 32.3 | 74,488 | Common Stock |
| Telos Corp | Edward L. Williams | EVP, COO | Sale of securities on an exchange or to another person at price $ 32.69 per share. | 30 Aug 2021 | 69,342 | 467,658 | - | 32.7 | 2,266,790 | Common Stock |
| Telos Corp | Edward L. Williams | EVP, COO | Sale of securities on an exchange or to another person at price $ 32.80 per share. | 30 Aug 2021 | 20,167 | 437,000 | - | 32.8 | 661,478 | Common Stock |
| Telos Corp | Edward L. Williams | EVP, COO | Sale of securities on an exchange or to another person at price $ 32.03 per share. | 30 Aug 2021 | 10,491 | 457,167 | - | 32.0 | 336,027 | Common Stock |
| Escalade, Inc. | Edward E. Williams | Director | Sale of securities on an exchange or to another person at price $ 23.11 per share. | 24 Aug 2021 | 125,000 | 289,487 (2%) | 0% | 23.1 | 2,888,800 | Common Stock |
| Telos Corp | Edward L. Williams | EVP, COO | Sale of securities on an exchange or to another person at price $ 29.32 per share. | 20 Aug 2021 | 23,434 | 149,793 | - | 29.3 | 687,085 | Common Stock |
| Telos Corp | Edward L. Williams | EVP, COO | Sale of securities on an exchange or to another person at price $ 27.73 per share. | 20 Aug 2021 | 19,684 | 180,109 | - | 27.7 | 545,837 | Common Stock |
| Telos Corp | Edward L. Williams | EVP, COO | Sale of securities on an exchange or to another person at price $ 28.59 per share. | 20 Aug 2021 | 6,882 | 173,227 | - | 28.6 | 196,756 | Common Stock |
| Telos Corp | Edward L. Williams | EVP, COO | Sale of securities on an exchange or to another person at price $ 29.09 per share. | 02 Aug 2021 | 9,192 | 200,810 | - | 29.1 | 267,395 | Common Stock |
| Telos Corp | Edward L. Williams | EVP, COO | Sale of securities on an exchange or to another person at price $ 29.52 per share. | 02 Aug 2021 | 1,017 | 199,793 | - | 29.5 | 30,022 | Common Stock |
| Telos Corp | Edward L. Williams | EVP, COO | Sale of securities on an exchange or to another person at price $ 27.96 per share. | 29 Jul 2021 | 100,000 | 537,000 | - | 28.0 | 2,796,000 | Common Stock |
| Telos Corp | Edward L. Williams | EVP, COO | Sale of securities on an exchange or to another person at price $ 27.96 per share. | 29 Jul 2021 | 39,791 | 210,002 | - | 28.0 | 1,112,556 | Common Stock |
| Telos Corp | Edward L. Williams | EVP, COO | Sale of securities on an exchange or to another person at price $ 28.19 per share. | 20 Jul 2021 | 40,000 | 637,000 | - | 28.2 | 1,127,600 | Common Stock |
| Telos Corp | Edward L. Williams | EVP, COO | Sale of securities on an exchange or to another person at price $ 28.03 per share. | 20 Jul 2021 | 31,782 | 705,218 | - | 28.0 | 890,849 | Common Stock |
| Telos Corp | Edward L. Williams | EVP, COO | Sale of securities on an exchange or to another person at price $ 28.49 per share. | 20 Jul 2021 | 28,218 | 677,000 | - | 28.5 | 803,931 | Common Stock |
| Telos Corp | Edward L. Williams | EVP, COO | Sale of securities on an exchange or to another person at price $ 31.53 per share. | 07 Jul 2021 | 25,000 | 249,793 | - | 31.5 | 788,250 | Common Stock |
| Telos Corp | Edward L. Williams | EVP, COO | Sale of securities on an exchange or to another person at price $ 32.12 per share. | 02 Jul 2021 | 1,109 | 737,091 | - | 32.1 | 35,621 | Common Stock |
| Telos Corp | Edward L. Williams | EVP, COO | Sale of securities on an exchange or to another person at price $ 32.78 per share. | 02 Jul 2021 | 91 | 737,000 | - | 32.8 | 2,983 | Common Stock |
| Telos Corp | Edward L. Williams | EVP, COO | Sale of securities on an exchange or to another person at price $ 32.79 per share. | 01 Jul 2021 | 31,599 | 745,401 | - | 32.8 | 1,036,131 | Common Stock |
| Telos Corp | Edward L. Williams | EVP, COO | Sale of securities on an exchange or to another person at price $ 33.14 per share. | 01 Jul 2021 | 7,078 | 738,323 | - | 33.1 | 234,565 | Common Stock |
| Telos Corp | Edward L. Williams | EVP, COO | Sale of securities on an exchange or to another person at price $ 34.07 per share. | 01 Jul 2021 | 123 | 738,200 | - | 34.1 | 4,191 | Common Stock |
| Catalyst Biosciences Inc | Edward Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2021 | 14,000 | 14,000 | - | - | Stock Option (Right to Buy) | |
| Catalyst Biosciences Inc | Edward Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2021 | 1,414 | 19,516 (0%) | 0% | 0 | Common Stock | |
| Telos Corp | Edward L. Williams | EVP, COO | Sale of securities on an exchange or to another person at price $ 33.00 per share. | 01 Apr 2021 | 662,959 | 274,793 | - | 33 | 21,877,647 | Common Stock |
| Telos Corp | Edward L. Williams | EVP, COO | Sale of securities on an exchange or to another person at price $ 33.00 per share. | 01 Apr 2021 | 150,000 | 777,000 | - | 33 | 4,950,000 | Common Stock |
| Catalyst Biosciences Inc | Edward Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2021 | 1,215 | 18,102 (0%) | 0% | 0 | Common Stock | |
| Escalade, Inc. | Edward E. Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Mar 2021 | 3,333 | 3,333 | - | - | Restricted Stock Unit | |
| Escalade, Inc. | Edward E. Williams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2021 | 2,500 | 2,500 | - | - | Restricted Stock Units | |
| Escalade, Inc. | Edward E. Williams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2021 | 2,500 | 138,394 (0%) | 0% | - | Common Stock | |
| Escalade, Inc. | Edward E. Williams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2021 | 1,425 | 0 | - | - | Restricted Stock Units | |
| Escalade, Inc. | Edward E. Williams | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Mar 2021 | 1,425 | 139,819 (0%) | 0% | - | Common Stock | |
| Telos Corp | Edward L. Williams | EVP, COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2021 | 52,941 | 887,752 | - | 0 | Common Stock | |
| Telos Corp | Edward L. Williams | EVP, COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2021 | 52,941 | 52,941 | - | - | Performance-Based RSUs | |
| Telos Corp | Edward L. Williams | EVP, COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2021 | 50,000 | 937,752 | - | 0 | Common Stock | |
| Catalyst Biosciences Inc | Edward Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2021 | 940 | 16,887 (0%) | 0% | 0 | Common Stock | |
| Telos Corp | Edward L. Williams | EVP, COO | Gift of securities by or to the insider at price $ 0.00 per share. | 22 Dec 2020 | 927,000 | 834,811 | - | 0 | Common Stock | |
| Telos Corp | Edward L. Williams | EVP, COO | Gift of securities by or to the insider at price $ 0.00 per share. | 22 Dec 2020 | 475,000 | 475,000 | - | 0 | Common Stock | |
| Telos Corp | Edward L. Williams | EVP, COO | Gift of securities by or to the insider at price $ 0.00 per share. | 22 Dec 2020 | 452,000 | 452,000 | - | 0 | Common Stock | |
| Telos Corp | Edward L. Williams | EVP, COO | Gift of securities by or to the insider at price $ 0.00 per share. | 22 Dec 2020 | 452,000 | 0 | - | 0 | Common Stock | |
| Telos Corp | Edward L. Williams | EVP, COO | Gift of securities by or to the insider at price $ 0.00 per share. | 22 Dec 2020 | 452,000 | 927,000 | - | 0 | Common Stock | |
| Catalyst Biosciences Inc | Edward Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Oct 2020 | 1,380 | 15,947 (0%) | 0% | 0 | Common Stock | |
| Catalyst Biosciences Inc | Edward Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2020 | 1,011 | 14,567 (0%) | 0% | 0 | Common Stock | |
| Catalyst Biosciences Inc | Edward Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2020 | 5,000 | 5,000 | - | - | Stock Option (Right to Buy) | |
| Catalyst Biosciences Inc | Edward Williams | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2020 | 2,717 | 13,556 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges